The GENE chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GENE chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The GENE stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View GENE Detailed Price Forecast - CNN Money | View GENE Detailed Summary - Google Finance | ||
View GENE Detailed Summary - Yahoo! Finance | View GENE Stock Research & Analysis - Zacks.com |
View GENE Trends & Analysis - Trade-Ideas | View GENE Major Holders - Barrons | ||
View GENE Call Transcripts - NASDAQ | View GENE Breaking News & Analysis - Seeking Alpha | ||
View GENE Annual Report - CompanySpotlight.com | View GENE OTC Short Report - OTCShortReport.com | ||
View GENE Fundamentals - TradeKing | View GENE SEC Filings - Bar Chart | ||
View Historical Prices for GENE - The WSJ | View Performance/Total Return for GENE - Morningstar | ||
View the Analyst Estimates for GENE - MarketWatch | View the Earnings History for GENE - CNBC | ||
View the GENE Earnings - StockMarketWatch | View GENE Buy or Sell Recommendations - MacroAxis | ||
View the GENE Bullish Patterns - American Bulls | View GENE Short Pain Metrics - ShortPainBot.com |
View GENE Stock Mentions - StockTwits | View GENE Stock Mentions - PennyStockTweets | ||
View GENE Stock Mentions - Twitter | View GENE Investment Forum News - Investor Hub | ||
View GENE Stock Mentions - Yahoo! Message Board | View GENE Stock Mentions - Seeking Alpha |
View Insider Transactions for GENE - SECform4.com | View Insider Transactions for GENE - Insider Cow | ||
View GENE Major Holdings Summary - CNBC | View Insider Disclosure for GENE - OTC Markets | ||
View Insider Transactions for GENE - Yahoo! Finance | View Institutional Holdings for GENE - NASDAQ |
View GENE Stock Insight & Charts - FinViz.com | View GENE Investment Charts - StockCharts.com | ||
View GENE Stock Overview & Charts - BarChart | View GENE User Generated Charts - Trading View |
Genetic Technologies Announces $2 Million Registered Direct Offering
Posted on Thursday April 18, 2024
MELBOURNE, Australia, April 19, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, "Company", "GTG", or "Genetic Technologies"), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, today announced that it has entered into a definitive agreement for the purchase and sale in a registered direct offering of 1,000,000 American Depositary Shares ("ADSs") (or ADS equivalents in lieu thereof), each representing thirty (30) ordinar
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
Posted on Wednesday April 17, 2024
MELBOURNE, Australia, April 17, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to announce the Company has established a precision oncology division and announced its highly anticipated portfolio of new diagnostic tests under its geneType precision oncology brand. The proprietary-developed tests will provide invaluable information to medical oncologists,
GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
Posted on Tuesday April 16, 2024
MELBOURNE, Australia, April 16, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to share the company’s latest milestones along with our clinical adoption of the Company’s groundbreaking geneType Risk Assessment Tests routinely across 12 states in the United States and nationally in Australia. The geneType team has achieved clinical proof of concept in key
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Posted on Friday April 12, 2024
ORLANDO, FL / ACCESSWIRE / April 12, 2024 / RedChip Companies will air interviews with Genetic Technologies Limited (NASDAQ:GENE) and BioVie, Inc. (NASDAQ:BIVI) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this ...